Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 42

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

A Correlation Between Tear Film Break–Up Patterns (TFBUP) and the Schirmer’s Test

E. Marsters; G.W. Ousler, III; M.R. Schindelar; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):277. doi:

ARVO Annual Meeting Abstract May 2006

Diurnal Signs and Symptoms Associated with Dry Eye

D.A. Workman; K. WilcoxHagberg; G.W. Ousler, III; G. Torkildsen; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):278. doi:

ARVO Annual Meeting Abstract May 2006

Seasonal Changes in Dry Eye Symptomatology

J.A. Davis; G.W. Ousler, III; N.A. Langelier; M.R. Schindelar; R. Abelson; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):280. doi:

ARVO Annual Meeting Abstract May 2006

Duration of Dry Eye Diagnosis and Tear Film Break Up Patterns (TFBUPs)

J.S. Casavant; G.W. Ousler, III; K. Wilcox Hagberg; M.R. Schindelar; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):282. doi:

ARVO Annual Meeting Abstract May 2006

Effect of Reflex Tearing on Tear Film Break up Time (TFBUT) and Tear Film Break–Up Patterns (TFBUP) in a Population of Ashkenazi Jewish Patients

K.A. Wilcox; G.W. Ousler, III; M.R. Schindelar; R.T. Anderson; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):283. doi:

ARVO Annual Meeting Abstract May 2006

Comparison of Topical and Systemic Anti–Allergy Treatments Relative to Ocular Dryness

G. Torkildsen; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4976. doi:

ARVO Annual Meeting Abstract May 2006

Evaluation of the Effect of Multiple Doses of Pred Forte (Prednisolone Acetate 1%) in the Prevention of Conjunctival Allergen Challenge–Induced Ocular Allergic Signs and Symptoms

P.J. Gomes; S. Yunes; D. Welch; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4978. doi:

ARVO Annual Meeting Abstract May 2006

Effect of Patanol on Tear Film Stability Stability

D. Welch; J.A. Davis; G. Torkildsen; G.W. Ousler, III; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4999. doi:

ARVO Annual Meeting Abstract May 2006

Perturbation of the Meibomian Glands and the Effect on Tear Film Stability and Tear Film Break Up Patterns (TFBUP) in an Ashkenazi Jewish Population

M.R. Schindelar; G.W. Ousler, III; S.L. Oberoi; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5610. doi:

ARVO Annual Meeting Abstract May 2006

A Pilot Evaluation to Identify Morning Eyelid Swelling Using a Three Dimensional (3D) Digital Scanner

A. Makino; K.J. Lane; M.J. Chapin; G.W. Ousler, III; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2272. doi:

ARVO Annual Meeting Abstract May 2006

A Randomized Trial Assessing Microbial Eradication and Clinical Efficacy of 1% Azithromycin Ophthalmic Solution vs. Tobramycin in Adult Subjects With Bacterial Conjunctivitis

M.B. Abelson; E.E. Protzko; A.M. Shapiro; AzaSite Clinical Study Group

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3589. doi:

ARVO Annual Meeting Abstract May 2005

Quality of Life in Rhinoconjunctivitis Sufferers and the Effects of Topical Ocular Therapy

N. MacDonald; P.J. Gomes; M.B. Abelson; W. Berger; M. Beck; S. Kimura; T. Westbrook; W. Storms; S. Galant

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):940. doi:

ARVO Annual Meeting Abstract May 2005

Evaluation of a Novel Anti–Inflammatory (rEV–131) Using Argon Laser Irradiation of the Iris in the Pigmented Rabbit

K. Lane; M.B. Abelson; M.J. Chapin; K. Goodhue; W. Weston–Davies

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):988. doi:

ARVO Annual Meeting Abstract May 2005

A Comparison of Performance Attributes Between a New Concept Artificial Tear and Systane® Lubricant Eye Drops

M.T. Christensen; D.L. Meadows; J.M. Stein; M.R. Tudor; R.P. Stone; M.B. Abelson; C. Michaelson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2016. doi:

ARVO Annual Meeting Abstract May 2005

Comparison of Pimecrolimus 1%, 0.3% and 0.1% With Vehicle for the Treatment of Dry Eye in the Controlled Adverse Environment (CAE) Model

G.W. Ousler; R. Haque; A. Weichselberger; N.C. Yannoulis; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2031. doi:

ARVO Annual Meeting Abstract May 2005

Evaluation of a Novel Dry Eye Oral Supplement for the Treatment of the Signs and Symptoms of Dry Eye in the Controlled Adverse Environment (CAE) Model

S.G. Pratt; G.W. Ousler; M. Schindelar; M.J. Chapin; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2047. doi:

ARVO Annual Meeting Abstract May 2005

A Correlation Between the Signs and Symptoms of Dry Eye and the Duration of Dry Eye Diagnosis

J. Casavant; G.W. Ousler, III; K. Wilcox Hagberg; D. Welch; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4455. doi:

ARVO Annual Meeting Abstract May 2005

Effect of Tear Film Stability on Ocular Surface Damage in a Population of Dry Eye Patients

M. Schindelar; G.W. Ousler, III; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4457. doi:

ARVO Annual Meeting Abstract May 2005

Effect of Menopause on the Ocular Protection Index (OPI) in a Population of Dry Eye Patients of Ashkenazi Jewish Descent

K.A. Wilcox Hagberg; G.W. Ousler, III; J.S. Casavant; D.L. Welch; M.B. Abelson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4470. doi:

ARVO Annual Meeting Abstract May 2005

Evaluation of Fluoroquinolone Antibiotic Concentrations in Human Conjunctival Tissue Following Topical Administration

R.S. Wagner; M.B. Abelson; A. Shapiro; G. Torkildsen

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4888. doi:

1 2 3

Next 20 Results »

Advertisement